Journal of Bone and Mineral Research · 1994 · 34 citations · 14 references
PharmacyPharmacokineticsPharmacologyDrug ClearanceRenal PharmacokineticsRenal PharmacotherapyPharmacokinetics In Renal ImpairmentRenal ClearanceRenal DiseaseRenal Dose AdjustmentRenal Drug ClearanceRenal PharmacologyChronic Renal InsufficiencyCumulative Urinary ExcretionPharmacokinetic ParametersRenal Clearance DeclineRenal Elimination KineticsRenal Elimination PathwaysRenal Function-based DosingRenal Plasma Clearance
The pharmacokinetic parameters describing the fate of one intravenous clodronate (disodium dichloromethane diphosphonate) dose was studied in 24 normal subjects and in 24 patients with different degrees of renal insufficiency. The aim of the study was to derive data for adjustment of dosage in relation to renal function. Disodium clodronate in serum and urine samples was analyzed by capillary gas chromatography with mass-selective detection. The renal clearance (CLR) of clodronate was highly dependent on renal function and declined successively with declining glomerular filtration rate (GFR). Plasma clearance (CLP) declined, too, but to a lesser degree than CLR. The impairment of renal function resulted in decreased cumulative urinary elimination of clodronate and increased total areas under the serum concentration-time curve (AUC0-infinity). Hence, as the renal elimination of clodronate diminishes with decreasing GFR, there is a related retention of the substance. As a result of the present study, the following dosages are recommended: creatinine clearance (CLCr) from 50 to 80 ml/minute, 75-100% of normal dose; CLCr 12-50 ml/minute, 50-75% of normal dose; and ClCr < 12 ml/minute, 50% of normal dose. The results must be interpreted with caution in patients with malignancy and severe skeletal disease, in whom the nonrenal clearance may vary markedly.
14
Oxford Textbook of Clinical Nephrology
George Dunea · JAMA · 1992 · 454 citations
Disorders of bone and mineral metabolism
Judith Saffran · Trends in Endocrinology and Metabolism · 1993 · 340 citations
Clodronate kinetics and bioavailability
Gerald J. Yakatan, Wesley J. Poynor, Robert L. Talbert et al. · Clinical Pharmacology & Therapeutics · 1982 · 119 citations
ABSORPTION OF ORAL DIPHOSPHONATE IN NORMAL SUBJECTS
I. Fogelman, Lachlan J. Smith, R. MAZESSS et al. · Clinical Endocrinology · 1986 · 118 citations